Literature DB >> 21048440

Toxicity of chemotherapy and radiation on female reproduction.

Dror Meirow1, Hannah Biederman, Richard A Anderson, W Hamish B Wallace.   

Abstract

One of the most devastating consequences of cancer treatment in the young female population is ovarian damage, resulting in diminished fertility potential. The extent of damage is related to age, chemotherapeutic regimen, and dose of pelvic radiation received. It is crucial that physicians know the impact each of these factors has on future fertility to advice patients on fertility preservation options. Anticancer drugs injure the female reproductive system through ovarian follicular and stromal damage. Although the exact mechanisms of damage remain unclear, it is essential to better understand these mechanisms to develop methods to diminish ovarian injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048440     DOI: 10.1097/GRF.0b013e3181f96b54

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  128 in total

1.  Spatial Analysis of Growing Follicles in the Human Ovary to Inform Tissue Engineering Strategies.

Authors:  Natalie Quan; Jamie N Mara; Allison R Grover; Mary Ellen Pavone; Francesca E Duncan
Journal:  Tissue Eng Part A       Date:  2020-06-26       Impact factor: 3.845

2.  Impact of cancer therapies on ovarian reserve.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen Freeman; Maureen Prewitt; Claire Carlson; Anushree Ray; Ashley Vance; Jill P Ginsberg
Journal:  Fertil Steril       Date:  2011-12-02       Impact factor: 7.329

Review 3.  Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Authors:  Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

4.  Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany.

Authors:  Andreas Müller; Katja Keller; Jennifer Wacker; Ralf Dittrich; Gudrun Keck; Markus Montag; Hans Van der Ven; David Wachter; Matthias W Beckmann; Wolfgang Distler
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

5.  How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics.

Authors:  K Hutt; J B Kerr; C L Scott; J K Findlay; A Strasser
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

6.  Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.

Authors:  Katherine Cameron; Mary D Sammel; Maureen Prewitt; Clarisa Gracia
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 7.  Management of fertility in patients treated for Hodgkin's lymphoma.

Authors:  Stephanie Harel; Christophe Fermé; Catherine Poirot
Journal:  Haematologica       Date:  2011-08-09       Impact factor: 9.941

8.  Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?

Authors:  Avner Hershlag; Christine Mullin; Sara L Bristow
Journal:  J Glob Oncol       Date:  2018-09

9.  Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.

Authors:  Malgorzata E Skaznik-Wikiel; Megan M McGuire; Meena Sukhwani; Julia Donohue; Tianjiao Chu; Thomas C Krivak; Aleksandar Rajkovic; Kyle E Orwig
Journal:  Fertil Steril       Date:  2013-02-26       Impact factor: 7.329

10.  Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.

Authors:  Joceline V Vu; Natalia C Llarena; Samantha L Estevez; Molly B Moravek; Jacqueline S Jeruss
Journal:  J Surg Oncol       Date:  2016-12-14       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.